Husky acquires medical/closure mould maker Schöttli

Canadian injection moulding machine maker Husky Injection Molding Systems, which is owned by Berkshire Partners and Omers Private Equity, has expanded its mould making portfolio with the acquisition of Schöttli Group from investment firm CGS. The Switzerland-based Schöttli is recognised in medical and closure mould making. The sale is expected to close in early December; terms were not disclosed. Husky also bought Austrian closure mould maker KTW Group in 2011.

Schöttli is a global leader in a number of select medical applications, such as syringes, infusion/transfusion products, diagnostic systems and feminine care items. Husky hot runner customers will benefit from product improvements based on strengthened knowledge, and existing Schöttli customers will have more streamlined access to Husky’s hot runner, controller and injection moulding machine products. In addition, Schöttli’s closures business complements Husky’s existing closures business by providing additional technology and capacity in both established and growing markets.

“Husky has enjoyed a strong and long-lasting relationship with Schöttli and we have long shared a mutual commitment to quality, technology innovation and customer satisfaction,” said John Galt, Husky’s President/CEO. “Through this acquisition, we will be able to work with the many skilled people at Schöttli as one team to deliver more value to customers, particularly in the medical and closures markets. Our goal is to expand our knowledge, expertise, capacity and global footprint so that we can provide the best possible support to customers in these areas of our business.”

Following the close of this transaction, Schöttli’s headquarters in Diessenhofen, Switzerland, as well as other facilities in San Dimas, California, and Suzhou, China, will become part of Husky’s global network of locations.

“As a technical leader with a growing customer base, we are proud of what our team has accomplished and have confidence this relationship will positively benefit customers,” said Thomas Anderegg, President/CEO of Schöttli. “By joining with Husky we are partnering with a like-minded industry leader to continue providing leading-edge technology, with the advantage of Husky’s extensive sales and service network to better support our global customer base. We are excited about this new chapter in our company’s history and look forward to the benefits and synergies this acquisition will bring.”

Industrial investor CGS took a majority stake in Schöttli back in early 2008 with the goal to form a global leader in mould making for medical applications and closures. Together with the former owner of Schöttli – Martin Schöttli – a buy and build strategy was implemented with add-on acquisitions in China and the US. The subsequent integration and global organisation enabled a considerable market share expansion and increased profitability. Through a special focus on innovation, several new technologies have been developed and will further support the growth path initiated over the recent years, says Schöttli.

(IMA)

  Home | Terms & Conditions | Privacy Policy | Contact | Webmail | Site Map  

Copyright (c) 2013 www.injectionmouldingasia.com. All rights reserved